BIO Stock: Bio-Rad Laboratories, Inc. Stock Price, Analysis & Insights
Get live bio stock price $304.11, comprehensive Bio-Rad Laboratories, Inc. stock analysis, charts, news, and expert forecast. Real-time bio stock data and investment insights.
Loading chart...
Company Overview
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Company Information
- CEO
- Norman D. Schwartz
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 7700
Contact Information
- Website
- https://www.bio-rad.com
- Address
- 1000 Alfred Nobel Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
Bio-Rad Laboratories, Inc. operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Norman D. Schwartz, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Bio-Rad Laboratories, Inc. competes in the Medical - Devices within the broader Healthcare. With 8.2 billion in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Bio-Rad Laboratories, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Bio-Rad Laboratories, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Bio-Rad Laboratories, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Bio-Rad Laboratories, Inc.
- ⚠Investors should consider how Bio-Rad Laboratories, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
8.20B
P/E Ratio
-12.66
Beta
1.19
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 8.20B market capitalization
- Trading Volume: 94.98K shares traded today
- Price Range: 52-week range of $211.43 - $373.69
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. (BIO) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 8.20B, the company represents a significant player in its market. The stock is currently trading at $304.11 with a negativedaily change of 2.89%.
The company's 7700 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -12.66, beta of 1.19, and 52-week price range from $211.43 to $373.69when evaluating investment opportunities.
Why Invest in Bio-Rad Laboratories, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Norman D. Schwartz
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.